Literature DB >> 8194474

Basic fibroblast growth factor receptor in the rat adrenal cortex: effects of suramin and unilateral adrenalectomy on receptor numbers.

D P Basile1, M A Holzwarth.   

Abstract

Previous studies have suggested that basic fibroblast growth factor (bFGF) is involved in the mediation of the compensatory adrenal growth response. These studies were undertaken to identify the bFGF receptor in the rat adrenal cortex and determine bFGF receptor levels in vivo. Initial studies using primary cultures of rat glomerulosa cells demonstrated a high affinity binding site with a Kd of 10 pM, consistent with reported values for the bFGF receptor; however, these results could not be demonstrated in capsule-glomerulosa tissue. Using autoradiography to verify the existence of bFGF receptors in vivo, heparin-insensitive [125I]bFGF-binding sites were concentrated primarily in the capsule and glomerulosa of the adrenal cortex, suggesting the presence of FGF receptors. The presence of bFGF receptors was further verified by demonstration of internalization of [125I]bFGF into cells of capsule-glomerulosa preps. This approach was used to demonstrate that suramin (a bFGF antagonist) pretreatment of rats results in bFGF receptor up-regulation in the adrenal cortex. In addition, we demonstrated a decrease in bFGF internalization in the remaining adrenal 24 h after unilateral adrenalectomy, suggesting the utilization of bFGF during the compensatory adrenal growth response. Together, these data support a role for bFGF in autocrine stimulation of the adrenal cortex and in the compensatory adrenal growth response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194474     DOI: 10.1210/endo.134.6.8194474

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

Review 1.  Regulation of the adrenocortical stem cell niche: implications for disease.

Authors:  Elisabeth M Walczak; Gary D Hammer
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

2.  In vitro growth suppression of human glioma cells by a 16-mer oligopeptide: a potential new treatment modality for malignant glioma.

Authors:  Katsuhiko Kono; Tetsuya Ueba; Jun A Takahashi; Nozomu Murai; Nobuo Hashimoto; Akira Myoumoto; Nobuo Itoh; Manabu Fukumoto
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

3.  Basic fibroblast growth factor delivery enhances adrenal cortical cellular regeneration.

Authors:  Yinting Chu; Won Jin Ho; James C Y Dunn
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

Review 4.  Adrenocortical zonation, renewal, and remodeling.

Authors:  Marjut Pihlajoki; Julia Dörner; Rebecca S Cochran; Markku Heikinheimo; David B Wilson
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-05       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.